Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations

American Journal of Surgery

Volumn 202, Issue 3, 2011, Pages 298-302

  Howard Mcnatt, Marissa ^a   Schroll, Rebecca W ^a   Hurt, Gail J ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA negative; Breast cancer; Contralateral prophylactic mastectomy

Indexed keywords

BIOLOGICAL MARKER; BRCA PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CONTRALATERAL PROPHYLACTIC MASTECTOMY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MARRIAGE; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RACE; RISK FACTOR; TUMOR LOCALIZATION;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; HETEROZYGOTE; HUMANS; MAMMAPLASTY; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; MUTATION; NORTH CAROLINA; SECONDARY PREVENTION;

EID: 80052143006     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2011.04.001     Document Type: Article

References (25)

1. E.M. John, A. Miron, and G. Gong Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups JAMA 298 2007 2869 2876
2. A. Antoniou, P.D. Pharoah, and S. Narod Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 2003 1117 1130 (Pubitemid 36530000)
3. D. Saslow, C. Boetes, and W. Burke American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2007 75 89 (Pubitemid 46535708)
4. National Comprehensive Cancer Network Genetic familial high-risk assessment: breast and ovarian http://www.nccn.org/ 2009 Accessed January, 2010
5. T.M. Tuttle, E.B. Habermann, and E.H. Grund Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment J Clin Oncol 25 2007 5203 5209 (Pubitemid 350232251)
6. L.J. Herrinton, W.E. Barlow, and O. Yu Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project J Clin Oncol 23 2005 4275 4286 (Pubitemid 46207002)
7. NIH Consensus Conference Treatment of early-stage breast cancer JAMA 265 1991 391 395
8. J.C. Boughey, T.L. Hoskin, and T.A. Dellars Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer (abstr) Ann Surg Oncol 17 Suppl 1 2010 72
9. T.M. Tuttle, S. Jarosek, and E.B. Habermann Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ J Clin Oncol 27 2009 1362 1367
10. R. Katipamula, A.C. Degnim, and T. Hoskin Trends in mastectomy rates at the Mayo Clinic Rochester: effects of surgical year and preoperative magnetic resonance imaging J Clin Oncol 27 2009 4082 4088
11. M.E. Sorbero, A.W. Dick, and E.B. Beckjord Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy Ann Surg Oncol 16 2009 1597 1605
12. A.K. Arrington, S.L. Jarosek, and B.A. Virnig Patient and tumor characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer Ann Surg Oncol 16 2009 2607 2704
13. E.T. Matloff, R.E. Barnett, and S.L. Bober Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers Cancer J 15 2009 15 18
14. L. Scheuer, N. Kauff, and M. Robson Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 2002 1260 1268 (Pubitemid 34177432)
15. K. Metcalfe, A. Poll, and A. O'Connor Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation Clin Genet 72 2007 208 217 (Pubitemid 47300023)
16. J.A. Ray, L.J. Loescher, and M. Brewer Risk-reduction surgery decisions in high-risk women seen for genetic counseling J Genet Couns 14 2005 473 484
17. D. Saslow, C. Boetes, and W. Burke American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2007 75 89 (Pubitemid 46535708)
18. B. Fisher, and C. Redmond New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent J Natl Cancer Inst 83 1991 1278 1280
19. L.E. Rutqvist, B. Cedermark, and U. Glas Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy J Natl Cancer Inst 83 1991 1299 1306
20. M. Baum, A.U. Budzar, and J. Cuzick ATAC Trialist's Group. Anastrozole alone or in combination with tamoxifen verses tamoxifen alone for adjuvant treatment of post-menopausal patients with breast cancer: first results of the ATAC randomised trial Lancet 359 2002 2131 2139 (Pubitemid 34694019)
21. J.K. Litton, S.N. Westin, and K. Ready Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation Cancer 15 2009 1598 1604
22. A. Geiger, L. Nekhlyudov, and L.J. Herrinton Quality of life after bilateral prophylactic mastectomy Ann Surg Oncol 14 2007 686 694 (Pubitemid 46175315)
23. A.M. Geiger, C.N. West, and L. Nekhlyudov Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy J Clin Oncol 24 2006 1350 1356 (Pubitemid 46621997)
24. L. Lostumbo, N. Carbine, and J. Wallace Prophylactic mastectomy for the prevention of breast cancer Cochrane Database Syst Rev 18 2004 CD002748
25. I. Bedrosian, C.Y. Hu, and G.J. Chang Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients J Natl Cancer Inst 102 2010 401 409